Comparison of Different Types of Resistant Starch

NCT ID: NCT00930956

Last Updated: 2010-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-05-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to determine whether different types of resistant starch have different effects on blood glucose in healthy adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each volunteer will visit the laboratory in a 10-12 hour fasted state on three occasions over a three-week period, up to two visits/wk, with at least 48 hours between visits. Volunteers will be asked to refrain from vigorous physical activity and the consumption of alcohol the day before each testing visit. Randomization using a Latin Square design was applied to minimize confounding issues associated with the order of administration.

In the morning of each test, a finger-prick capillary blood samples will be collected to determine fasting (baseline) blood glucose levels. The volunteers will then consume the test solution assigned for that trial. Ten minutes will be allowed for the test solution to be consumed. Over the two hours following the start of each test, finger-prick capillary blood samples were collected at 30, 60, 90, and 120 min. Blood glucose levels will be immediately measured in duplicate using an automated blood glucose analyzer (YSI 2300, Yellow Springs, OH). Analysis of the collected sample was repeated if the difference between duplicate samples was greater than 0.1 mmol/L. Once the samples were analyzed, the data was entered and the incremental area under the curve was calculated using the trapezoidal model (GraphPad v5.0, La Jolla, CA).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postprandial Hyperglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dextrose

30 g of carbohydrate via Sun-Dex OGTT beverage

Group Type ACTIVE_COMPARATOR

Resistant Starch

Intervention Type DIETARY_SUPPLEMENT

30 g of carbohydrate per Arm

RS Type 2

30g Resistant Starch Type 2 (Hi-Maize 260, National Starch)

Group Type EXPERIMENTAL

Resistant Starch

Intervention Type DIETARY_SUPPLEMENT

30 g of carbohydrate per Arm

RS Type 4 (cross linked)

30g of cross linked RS type 4 (Fibersym RW, MGP Ingredients, Inc.)

Group Type EXPERIMENTAL

Resistant Starch

Intervention Type DIETARY_SUPPLEMENT

30 g of carbohydrate per Arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resistant Starch

30 g of carbohydrate per Arm

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hi-Maize 260 Fibersym RW

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* apparently healthy

Exclusion Criteria

* diagnosis of any chronic disease
* wheat allergy
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kansas State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kansas State University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark D Haub, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Kansas State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Human Metabolism Laboratory (K-State Univ.)

Manhattan, Kansas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KSUHML09-RS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Clinical Trial of Ginseng in Diabetes
NCT00781534 COMPLETED EARLY_PHASE1